2nd Quarter - Report

NOVO NORDISK INC. for NOVO NORDISK INC.

Firm
Client
Income
—
Expenses
$690,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

P.L. 114-26 Bipartisan Congressional Trade Priorities and Accountability Act of 2015; EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property, regulatory harmonization)

LobbyistCovered position, as disclosed
BRIAN BRANTON —
TRICIA BROOKS —
AMANDA MAKKI US Senator Lisa Murkowski (R-AK)
SARAH ELIZABETH NORDSTROM —
LAUREN ELIZABETH SEMENIUK —
AMY WOTRING —

Contacted: Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); Treasury, Dept of; Centers For Disease Control & Prevention (CDC); Indian Health Service; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS)

Defense DEF

Issues related to TRICARE pharmacy benefit in HR4909 and S 2943 FY17 National Defense Authorization Act.

LobbyistCovered position, as disclosed
BRIAN BRANTON —
TRICIA BROOKS —
AMANDA MAKKI US Senator Lisa Murkowski (R-AK)
SARAH ELIZABETH NORDSTROM —
LAUREN ELIZABETH SEMENIUK —
AMY WOTRING —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Treasury, Dept of; Labor, Dept of (DOL); Indian Health Service; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4909 (114th)

Taxation/Internal Revenue Code TAX

Protecting Americans from Tax Hikes Act of 2015(PATH) provision of P.L. 114-113 FY16 Consolidated Appropriations; H.R. 880 R&D tax credit; corporate tax inversion generally and in amendments to S.Con.Res.11 FY16 Senate Budget Resolution and S. 1376 FY16 National Defense Authorization Act; interest deductibility IRC 163(j); Treasury proposed debt and equity regulations (Sec. 385)

LobbyistCovered position, as disclosed
BRIAN BRANTON —
TRICIA BROOKS —
AMANDA MAKKI US Senator Lisa Murkowski (R-AK)
SARAH ELIZABETH NORDSTROM —
LAUREN ELIZABETH SEMENIUK —
AMY WOTRING —

Contacted: Executive Office of the President (EOP); Indian Health Service; Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; Treasury, Dept of; Health Resources & Services Administration (HRSA)

Bills named: S. 1376 (114th), S.Con.Res. 11 (114th), H.R. 880 (114th)

Copyright/Patent/Trademark CPT

H.R. 9 Innovation Act and and S. 1137 PATENT Act (patent litigation and assertion); S.1890 and H.R.3326 Defend Trade Secrets Act of 2015

LobbyistCovered position, as disclosed
BRIAN BRANTON —
TRICIA BROOKS —
AMANDA MAKKI US Senator Lisa Murkowski (R-AK)
SARAH ELIZABETH NORDSTROM —
LAUREN ELIZABETH SEMENIUK —
AMY WOTRING —

Contacted: Indian Health Service; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE; Labor, Dept of (DOL); Treasury, Dept of; Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH)

Bills named: H.R. 3326 (114th), S. 1890 (114th), S. 1137 (114th), H.R. 9 (114th)

Health Issues HCR

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1192 and S. 586 National Diabetes Clinical Care Commission Act of 2015; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing; Congressional recognition of World Hemophilia Day

LobbyistCovered position, as disclosed
BRIAN BRANTON —
TRICIA BROOKS —
AMANDA MAKKI US Senator Lisa Murkowski (R-AK)
SARAH ELIZABETH NORDSTROM —
LAUREN ELIZABETH SEMENIUK —
AMY WOTRING —

Contacted: Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH); Labor, Dept of (DOL); Indian Health Service; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of

Bills named: H.R. 2651 (114th), H.R. 744 (114th), H.R. 3658 (114th), S. 84 (114th), H.R. 3742 (114th), S. 2023 (114th), H.R. 3513 (114th), S. 320 (114th), H.R. 1192 (114th), S. 141 (114th), H.R. 1190 (114th), S. 586 (114th)

Pharmacy PHA

P.L. 113-54 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; issues regarding 340B; H.R.6 21st Century Cures Act; FDA in HR 3049 FY16 Agriculture Appropriations

LobbyistCovered position, as disclosed
BRIAN BRANTON —
TRICIA BROOKS —
AMANDA MAKKI US Senator Lisa Murkowski (R-AK)
SARAH ELIZABETH NORDSTROM —
LAUREN ELIZABETH SEMENIUK —
AMY WOTRING —

Contacted: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); SENATE; Treasury, Dept of; Labor, Dept of (DOL); Indian Health Service; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Bills named: H.R. 3049 (114th), H.R. 6 (114th)

Medicare/Medicaid MMM

Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 2102 and S.1131 Medicare Diabetes Prevention Act; H.R. 2404 and S. 1509 Treat and Reduce Obesity Act; Issues related to medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing type 2 diabetes H.R. 1686 Medical Nutrition Therapy 2015; issues related to patient diabetes education in H.R. 1726 Access to Quality Diabetes Education Act of 2015; Continuous Glucose Monitoring (CGM); Medicare diabetes screening generally; H.R. 1021 Protecting the Integrity of Medicare Act (PIMA) of 2015; H.R.2005 and S. 1083 Medicare Drug Savings Act of 2015; Physician Quality and Reporting System (PQRS); CMMI Part B Demonstration

LobbyistCovered position, as disclosed
BRIAN BRANTON —
TRICIA BROOKS —
AMANDA MAKKI US Senator Lisa Murkowski (R-AK)
SARAH ELIZABETH NORDSTROM —
LAUREN ELIZABETH SEMENIUK —
AMY WOTRING —

Contacted: Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Executive Office of the President (EOP); Treasury, Dept of; Health Resources & Services Administration (HRSA); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Indian Health Service

Bills named: H.R. 2404 (114th), H.R. 1726 (114th), H.R. 1686 (114th), H.R. 2005 (114th), H.R. 1021 (114th), S. 1509 (114th), S. 1131 (114th), S. 1083 (114th), H.R. 2102 (114th)

Budget/Appropriations BUD

Issues related to National Diabetes Prevention Program in FY17 Labor/HHS/Education Appropriations, P.L. 114-113 FY16 Consolidated Appropriations, and P.L. 113-235 FY15 Consolidated and Continuing Appropriations; Issues related to Medicare Part D, FDA, patents, and federal procurement in S.Con.Res.11 FY16 Senate Budget Resolution and H.Con.Res.27 House Budget Resolution; H.R. 3660 and S.3126 Preventive Health Savings Act

LobbyistCovered position, as disclosed
BRIAN BRANTON —
TRICIA BROOKS —
AMANDA MAKKI US Senator Lisa Murkowski (R-AK)
SARAH ELIZABETH NORDSTROM —
LAUREN ELIZABETH SEMENIUK —
AMY WOTRING —

Contacted: Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Indian Health Service; Health & Human Services, Dept of (HHS); Treasury, Dept of; SENATE

Bills named: H.R. 3660 (114th), S. 3126 (114th), H.Con.Res. 27 (114th), S.Con.Res. 11 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.